Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer.

International journal of cancer - 1 Dec 2007

Ivansson Emma L, Gustavsson Inger M, Magnusson Jessica J, Steiner Lori L, Magnusson Patrik K E, Erlich Henry A, Gyllensten Ulf B

Abstract excerpt

Cervical cancer is caused by persistent infection of oncogenic human papillomavirus (HPV). Most infected women clear the virus without developing cervical lesions and it is likely that immunological host factors affect susceptibility to cervical cancer. The impact of the human leukocyte antigen (HLA) locus on the risk of cervical cancer is established and several other genes involved in immunological pathways...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fas Ligand Protein
Share to Odds Ratio

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptors, CCR2

Share to Receptors, Interleukin-4

Share to Registries

Share to Risk Assessment

Share to Sweden

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 17688234
DOI: 10.1002/ijc.22989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer.PMID 17688234Read ↗

CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.Semantic proximity Read ↗

Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease.Semantic proximity Read ↗

Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review.Semantic proximity Read ↗

Host genetic polymorphism analysis in cervical cancer.Semantic proximity Read ↗

Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers?Semantic proximity Read ↗

Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer RiskSemantic proximity Read ↗

Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population.Semantic proximity Read ↗

CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study.Semantic proximity Read ↗

Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.Semantic proximity Read ↗

Analysis of the association between <i>rs111200466</i> variants and cervical Cancer susceptibility in Sudanese womenSemantic proximity Read ↗

The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis.Semantic proximity Read ↗

Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.